MRI and blood tests to predict if pancreatic surgery is possible
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have pancreatic cancer (PDAC) that is considered borderline resectable or locally advanced, not spread to distant organs
- Have a tissue-based diagnosis confirming pancreatic cancer (not cholangiocarcinoma, duodenal cancer, or a neuroendocrine tumor)
- Be able to have surgery (no medical/anesthesia reasons preventing surgery)
- Be able to do MRI and the study: no severe MRI contrast allergy, no MRI-incompatible pacemaker or metal, and not severe claustrophobia
- Be able to understand the study and sign consent; agree to also avoid pregnancy during the study (not pregnant or breastfeeding)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This study tests a new, harmless “disposable” setup for MRI scans to measure how pancreatic cancer treatments affect the body. It may help doctors get more accurate MRI measurements, so treatment response can be assessed better.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
This study looks at a special blood test (miRNA panel) to see if it can help predict how well treatment works for people with advanced pancreatic cancer. If you are starting FOLFIRINOX for the first time, you may be able to join.
This study tests a highly focused radiation plan that uses MRI scans to adjust treatment during therapy. It’s for people with locally advanced pancreatic cancer who have already completed a set course of chemotherapy and whose cancer hasn’t grown.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.